A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

NCT05515536 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Friedreich Ataxia

Interventions

DRUG: Vatiquinone

Sponsor

PTC Therapeutics